{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:33:04Z","timestamp":1784374384804,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>All chronic wounds are colonised by bacteria; for some, colonisation progresses to become infection. Alginate wound dressings are used for highly exuding chronic wounds as they are very absorbent, taking up large quantities of exudate while maintaining a moist wound bed to support healing. Some alginate dressings are doped with antimicrobials, most commonly silver, but evidence regarding the efficacy of these is largely inconclusive. This manuscript describes the development and in vitro assessment of alginate materials doped with chlorhexidine hexametaphosphate (CHX-HMP), a sparingly soluble salt which when exposed to aqueous environments provides sustained release of the common antiseptic chlorhexidine. Comparator materials were a commercial silver alginate dressing material and an alginate doped with chlorhexidine digluconate (CHXdg). CHX-HMP alginates provided a dose-dependent CHX release which was sustained for over 14 days, whereas CHXdg alginates released limited CHX and this ceased within 24\u2009h. CHX-HMP and silver alginates were efficacious against 5 major wound pathogens (MRSA,<jats:italic>E. coli, P. aeruginosa, K. pneumoniae, A. baumannii<\/jats:italic>) in a total viable count (TVC) and an agar diffusion zone of inhibition (ZOI) model. At baseline the silver alginate was more effective than the CHX-HMP alginate in the TVC assay but the CHX-HMP alginate was the more effective in the ZOI assay. After 7 days\u2019 artificial aging the CHX-HMP alginate was more effective than the silver alginate for four of the five bacteria tested in both assays. These materials may ultimately find application in the development of wound dressings for chronic wounds that provide sustained antimicrobial protection.<\/jats:p>","DOI":"10.1007\/s10856-020-06370-0","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T14:02:48Z","timestamp":1583935368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Alginate films augmented with chlorhexidine hexametaphosphate particles provide sustained antimicrobial properties for application in wound care"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5504-2369","authenticated-orcid":false,"given":"Peter F.","family":"Duckworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2452-3757","authenticated-orcid":false,"given":"Sarah E.","family":"Maddocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7127-1818","authenticated-orcid":false,"given":"Sameer S.","family":"Rahatekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2012-2745","authenticated-orcid":false,"given":"Michele E.","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"6370_CR1","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","volume":"387","author":"NCD-RisC.","year":"2016","unstructured":"NCD-RisC. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513\u201330.","journal-title":"Lancet."},{"key":"6370_CR2","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/iwj.12932","volume":"15","author":"JJ Hurlow","year":"2018","unstructured":"Hurlow JJ, Humphreys GJ, Bowling FL, McBain AJ. Diabetic foot infection: a critical complication. Int Wound J. 2018;15:814\u201321.","journal-title":"Int Wound J."},{"key":"6370_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40266-016-0343-8","volume":"33","author":"DJ Pugliese","year":"2016","unstructured":"Pugliese DJ. Infection in venous leg ulcers: considerations for optimal management in the elderly. Drugs Aging. 2016;33:87\u201396.","journal-title":"Drugs Aging."},{"key":"6370_CR4","doi-asserted-by":"crossref","unstructured":"O\u2019Meara S, Al-Kurdi D, Ologun Y, Ovington L, Martyn-St James M, Richardson R. Antibiotics and antiseptics for venous leg ulcers (Review). Cochrane Database Syst Rev. 2014;CD003557.","DOI":"10.1002\/14651858.CD003557.pub5"},{"key":"6370_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s40257-013-0046-4","volume":"14","author":"KC Broussard","year":"2013","unstructured":"Broussard KC, Gloeckner J. Wound dressings: selecting the most appropriate type. Am J Clin Dermatol. 2013;14:449\u201359.","journal-title":"Am J Clin Dermatol"},{"key":"6370_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jaad.2009.09.007","volume":"63","author":"MJ Carter","year":"2010","unstructured":"Carter MJ, Tingley-Kelley K, Warriner RAI. Silver treatments and silver-impregnated dressings for the healing of leg wounds and ulcers: a systematic review and meta-analysis. J Am Dermatol. 2010;63:668\u201379.","journal-title":"J Am Dermatol"},{"key":"6370_CR7","doi-asserted-by":"crossref","unstructured":"Bergin S, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers (Review). Cochrane Database Syst Rev. 2006;CD005082.","DOI":"10.1002\/14651858.CD005082.pub2"},{"key":"6370_CR8","doi-asserted-by":"crossref","unstructured":"Storm-Versloot M, Vos C, Ubbink D, Vermeulen H. Topical silver for preventing wound infection (Review). Cochrane Database Syst Rev. 2010;CD006478.","DOI":"10.1002\/14651858.CD006478.pub2"},{"key":"6370_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1742-481X.2010.00705.x","volume":"7","author":"MH Cavanagh","year":"2010","unstructured":"Cavanagh MH, Burrell RE, Nadworny PL. Evaluating antimicrobial efficacy of new commercially available silver dressings. Int Wound J. 2010;7:394\u2013405.","journal-title":"Int Wound J."},{"key":"6370_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ajic.2016.09.017","volume":"45","author":"G Privitera","year":"2017","unstructured":"Privitera G, Costa A, Brusaferro S, Chirletti P, Crosasso P, Massimetti G, et al. Skin antisepsis with chlorhexidine versus iodine for the prevention of surgical site infection: a systematic review and meta-analysis. Am J Infect Control. 2017;45:180\u20139.","journal-title":"Am J Infect Control"},{"key":"6370_CR11","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1097\/CCM.0000000000000319","volume":"42","author":"N Safdar","year":"2014","unstructured":"Safdar N, Horo JCO, Ghufran A, Bearden A, Didier ME, Chateau D, et al. Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: A meta-analysis. Crit Care Med. 2014;42:1703\u201313.","journal-title":"Crit Care Med."},{"key":"6370_CR12","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.2147\/IJN.S50140","volume":"8","author":"ME Barbour","year":"2013","unstructured":"Barbour ME, Maddocks SE, Wood NJ, Collins AM. Synthesis, characterization, and efficacy of antimicrobial chlorhexidine hexametaphosphate nanoparticles for applications in biomedical materials and consumer products. Int J Nanomed. 2013;8:3507\u201319.","journal-title":"Int J Nanomed"},{"issue":"16","key":"6370_CR13","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.2217\/nnm-2016-0084","volume":"11","author":"Michele E Barbour","year":"2016","unstructured":"Barbour ME, Maddocks SE, Grady HJ, Roper JA, Bass MD, Collins AM, et al. Chlorhexidine hexametaphosphate as a wound care material coating: antimicrobial efficacy, toxicity and effect on healing. Nanomed. 2016;11:2049\u201357. http:\/\/www.futuremedicine.com\/, https:\/\/doi.org\/10.2217\/nnm-2016-0084.","journal-title":"Nanomedicine"},{"key":"6370_CR14","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.dental.2018.09.003.","volume":"34","author":"CA Bellis","year":"2018","unstructured":"Bellis CA, Addison O, Nobbs AH, Duckworth PF, Holder JA, Barbour ME. Glass ionomer cements with milled, dry chlorhexidine hexametaphosphate filler particles to provide long-term antimicrobial properties with recharge capacity. Dent Mater. Acad of Dent Mater. 2018;34:1717\u201326. https:\/\/doi.org\/10.1016\/j.dental.2018.09.003.","journal-title":"Dent Mater. Acad of Dent Mater"},{"key":"6370_CR15","first-page":"732","volume":"38","author":"AA Miles","year":"1938","unstructured":"Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal power of the blood. J Hyg (Lond). 1938;38:732\u201349.","journal-title":"J Hyg (Lond)"},{"key":"6370_CR16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF00766694","volume":"19","author":"MS Goizman","year":"1985","unstructured":"Goizman MS, Sarkisyan SO, Sarkisyan AA, Persianova IV. Differential spectrophotometric determination of biguanide derivatives. Pharm Chem J. 1985;19:503\u20138.","journal-title":"Pharm Chem J."},{"key":"6370_CR17","doi-asserted-by":"publisher","first-page":"16147","DOI":"10.1021\/ja9051125","volume":"131","author":"S Pal","year":"2009","unstructured":"Pal S, Yoon EJ, Tak YK, Choi EC, Song JM. Synthesis of highly antibacterial nanocrystalline trivalent silver polydiguanide. J Am Chem Soc. 2009;131:16147\u201355.","journal-title":"J Am Chem Soc."},{"key":"6370_CR18","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1002\/anie.201208889.","volume":"52","author":"M Gr\u00e4ber","year":"2013","unstructured":"Gr\u00e4ber M, Hell M, Gr\u00f6st C, Friberg A, Sperl B, Sattler M. et al. Oral disinfectants inhibit protein\u2013protein interactions mediated by the anti\u2010apoptotic protein bcl\u2010xl and induce apoptosis in human oral tumor cells. Angew Chemie Int Ed. 2013;52:4487\u201391. https:\/\/doi.org\/10.1002\/anie.201208889.","journal-title":"Angew Chemie Int Ed"},{"key":"6370_CR19","first-page":"2163","volume":"13","author":"N Shankaraiah","year":"2009","unstructured":"Shankaraiah N, Markandeya N, Espinoza-Moraga M, Arancibia C, Kamal A, Silva Santos L. One-pot microwave-assisted selective azido reduction\/tandem cyclization in condensed and solid phase with nickel boride. Synthesis (Stuttg). 2009;13:2163\u201370.","journal-title":"Synthesis (Stuttg)."},{"key":"6370_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0022-4596(95)80031-J","volume":"119","author":"O Elmokhtar","year":"1995","unstructured":"Elmokhtar O, Rzaigui M. Preparation et caracterisation d\u2019une serie de cyclohexaphosphates de terres rares. J Solid State Chem. 1995;119:203\u20136.","journal-title":"J Solid State Chem."},{"key":"6370_CR21","first-page":"3391","volume":"48","author":"Z Zhou","year":"2012","unstructured":"Zhou Z, Kang X, Song Y, Chen S. Enhancement of the electrocatalytic activity of Pt nanoparticles in oxygen reduction by chlorophenyl functionalization. ChemComm. 2012;48:3391\u20133.","journal-title":"ChemComm."},{"key":"6370_CR22","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/jbm.820281116","volume":"28","author":"DN Misra","year":"1994","unstructured":"Misra DN. Interaction of chlorhexidine digluconate with and adsorption of chlorhexidine on hydroxyapatite. J Biomed Mater Res. 1994;28:1375\u201381.","journal-title":"J Biomed Mater Res."},{"key":"6370_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S1003-6326(11)60701-2.","volume":"21","author":"Y Lu","year":"2010","unstructured":"Lu Y, Zhang M, Feng Q, Long T, Ou L, Zhang G. Effect of sodium hexametaphosphate on separation of serpentine from pyrite. Trans Nonferrous Met Soc China. 2010;21:208\u201313. https:\/\/doi.org\/10.1016\/S1003-6326(11)60701-2.","journal-title":"Trans Nonferrous Met Soc China"},{"key":"6370_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/dth.12055","volume":"26","author":"JG Powers","year":"2013","unstructured":"Powers JG, Morton LM, Phillips TJ. Dressings for chronic wounds. Dermatol Ther. 2013;26:197\u2013206.","journal-title":"Dermatol Ther."},{"key":"6370_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1586\/14787210.2015.1023291","volume":"13","author":"R Serra","year":"2015","unstructured":"Serra R, Grande R, Butrico L, Rossi A, Settimio UF, Caroleo B, et al. Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus. Expert Rev Anti Infect Ther. 2015;13:605\u201313.","journal-title":"Expert Rev Anti Infect Ther."},{"key":"6370_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/omi.12174","volume":"32","author":"C Withycombe","year":"2017","unstructured":"Withycombe C, Purdy KJ, Maddocks SE. Micro-management: curbing chronic wound infection. Mol Oral Microbiol. 2017;32:263\u201374.","journal-title":"Mol Oral Microbiol."},{"key":"6370_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/1534734615572825","volume":"14","author":"M Wu","year":"2015","unstructured":"Wu M, Ruan H, Huang Y, Liu C, Ni P, Ye J, et al. Bacteriological investigation of chronic wounds in a specialized wound healing department: a retrospective analysis of 107 Cases. Int J Low Extrem Wounds. 2015;14:178\u201382.","journal-title":"Int J Low Extrem Wounds."},{"key":"6370_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.pathol.2017.05.008","volume":"49","author":"C Hughes","year":"2017","unstructured":"Hughes C, Ferguson J. Phenotypic chlorhexidine and triclosan susceptibility in clinical Staphylococcus aureus isolates in Australia. Pathology. 2017;49:633\u20137.","journal-title":"Pathology."},{"key":"6370_CR29","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s11999-008-0212-9","volume":"466","author":"JH Calhoun","year":"2008","unstructured":"Calhoun JH, Murray CK, Manring MM. Multidrug-resistant organisms in military wounds from iraq and afghanistan. Clin Orthop Relat Res. 2008;466:1356\u201362.","journal-title":"Clin Orthop Relat Res."},{"key":"6370_CR30","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/01.sla.0000251707.32332.c1","volume":"245","author":"K Petersen","year":"2007","unstructured":"Petersen K, Riddle MS, Danko JR, Dunne JR. Trauma-related infections in battlefield casualties. Ann Surg. 2007;245:803\u201311.","journal-title":"Ann Surg."},{"key":"6370_CR31","first-page":"172","volume":"30","author":"NA Latifi","year":"2017","unstructured":"Latifi NA, Karimi H. Correlation of occurrence of infection in burn patients. Ann Burns Fire Disasters. 2017;30:172\u20136.","journal-title":"Ann Burns Fire Disasters"},{"key":"6370_CR32","first-page":"102","volume":"3","author":"N Taneja","year":"2013","unstructured":"Taneja N, Chari PS, Singh M, Singh G, Biswal M, Sharma M. Evolution of bacterial flora in burn wounds: key role of environmental disinfection in control of infection. Int J Burns Trauma. 2013;3:102\u20137.","journal-title":"Int J Burns Trauma"},{"key":"6370_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10856-014-5343-9","volume":"26","author":"C Wiegand","year":"2015","unstructured":"Wiegand C, Abel M, Ruth P, Elsner P, Hipler U-C. A. In vitro assessment of the antimicrobial activity of wound dressings: influence of the test method selected and impact of the pH. J Mater Sci Mater Med. 2015;26:18.","journal-title":"J Mater Sci Mater Med."}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-020-06370-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10856-020-06370-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-020-06370-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T11:18:56Z","timestamp":1666091936000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10856-020-06370-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["6370"],"URL":"https:\/\/doi.org\/10.1007\/s10856-020-06370-0","relation":{},"ISSN":["0957-4530","1573-4838"],"issn-type":[{"value":"0957-4530","type":"print"},{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"11 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MEB is founder and director of Pertinax Pharma Ltd, a University of Bristol spin-out company formed to commercialise sustained efficacy chlorhexidine technologies. She is also named inventor on a patent application regarding chlorhexidine polyphosphates. The other authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"33"}}